AnalystsCory JubinvilleCory Jubinville's Stock Forecasts
AnalystsCory Jubinville
Sectors:
Analyst Ranking
Bottom 33%
#3717 out of 5510 analysts
Average Return
-1.28%
Win Rate
33%1 out of 3
Risk vs Reward
Poor
Good
Cory Jubinville's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Liquidia CorpLQDA | +117.05% | $10.09 | $21.90 | 2024-10-03 - 2025-10-02 | Buy |
Cory Jubinville Analyst Color
Get additional color on Cory Jubinville's coverage of popular stocks
Cory Jubinville's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mereo Biopharma Group PLCMREO | 2 | Hold | N/A | N/A | Downgrades | 9 months ago |
Sionna Therapeutics IncSION | 1 | Buy | $60.00 | +626.39% | Initiates Coverage On | 9 months ago |
Verve Therapeutics IncVERV | 1 | Hold | $12.00 | N/A | Downgrades | a year ago |
Liquidia CorpLQDA | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Cymabay Therapeutics IncCBAY | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.